Intercept Pharmaceuticals' (ICPT) stunning 280% gain on Thursday left shareholders smiling. Some may have expected shares to pull back today, as investors tend to lock in profits after such big gains, but the stock popped more than 60% today. In the following video, analysts David Williamson and Max Macaluso discuss this stock's stellar performance and why investors are pushing shares higher.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Why Intercept Pharmaceuticals popped again today.
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
David Williamson has no position in any stocks mentioned. Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned
Intercept Pharmaceuticals
ICPT
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Meet the 3%-Yielding Dividend Stock That Could Soar in 2026
3 Things You Need to Know if You Buy Pfizer Today
This Medical Device Giant Could Be Your Best Inflation Hedge
Why AbbVie Stock Cruised to an Almost 6% Gain Today
Why BioNTech Stock Jumped by Nearly 4% on Wednesday
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.